Skip to main content

Want a detailed portfolio tracker?

Athira Pharma (ATHA) P/E (2020 - 2026)

Athira Pharma (ATHA) P/E from Sep 30, 2020 to Jun 5, 2026. The TTM Athira Pharma (ATHA) P/E is -0.52. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Athira Pharma (ATHA)

YearP/EChange
2026-0.52+0.58%
2025-0.52+121.17%
2024-0.23-69.52%
2023-0.77-47.52%
2022-1.46-83.53%
2021-8.86-86.83%
2020-67.27N/A

Comparison Athira Pharma (ATHA) P/E with competitors

Athira Pharma (ATHA) P/E is -0.52.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.33%
NBYStablecoin Development Corp0.00-100.83%
ENLVEnlivex Ltd0.07-114.40%
FGENFibroGen Inc0.24-146.22%
CHRSCoherus Biosciences Inc0.85-263.40%
FBIOFortress Biotech Inc0.95-282.75%
ORMPOramed Pharmaceuticals Inc1.50-389.44%
AGENAgenus Inc3.01-679.55%
INVAInnoviva Inc3.15-707.36%
VXRTVaxart Inc3.55-783.56%
CRMDCorMedix Inc3.63-798.72%
CVACCureVac N.V.4.45-956.09%
GLPGGalapagos NV4.86-1035.66%
SRPTSarepta Therapeutics Inc4.88-1040.13%
ABEOAbeona Therapeutics Inc5.39-1137.46%
ABUSArbutus Biopharma Corp5.60-1177.53%
ZVRAZevra Therapeutics Inc5.89-1233.69%
SPROSpero Therapeutics Inc6.23-1299.39%
CGENCompugen Ltd6.31-1315.86%
RIGLRigel Pharmaceuticals6.87-1423.33%
SLXNSilexion Therapeutics Corp7.30-1504.99%
OMEROmeros Corporation9.26-1882.93%
AUPHAurinia Pharmaceuticals Inc9.58-1945.75%
PLXProtalix BioTherapeutics Inc10.89-2197.25%
ACADAcadia Pharmaceuticals Inc11.73-2358.54%
TBPHTheravance Biopharma Inc12.26-2461.29%
ADMAAdma Biologics Inc12.42-2491.33%
HRMYHarmony Biosciences Holdings Inc13.82-2761.32%
SABSSAB Biotherapeutics Inc14.14-2822.18%
NAGENiagen Bioscience Inc14.82-2953.49%
INCYIncyte Corp15.82-3146.92%
REGNRegeneron Pharmaceuticals Inc15.86-3153.48%
PBYIPuma Biotechnology Inc17.32-3434.45%
CPRXCatalyst Pharmaceuticals Inc17.44-3458.25%
EXELExelixis Inc17.54-3477.26%
TGTXTG Therapeutics Inc18.97-3752.26%
MDXGMimedx Group Inc20.55-4057.76%
XOMAXOMA Royalty Corp22.87-4505.05%
ARGXArgen X SE24.30-4779.14%
CTMXCytomX Therapeutics Inc24.82-4879.88%
XOMAOXOMA Royalty Corp25.34-4980.73%
HALOHalozyme Therapeutics Inc25.62-5034.44%
XOMAPXOMA Royalty Corp25.67-5043.37%
VRTXVertex Pharmaceuticals Inc27.99-5491.03%
RPRXRoyalty Pharma plc - Class A28.69-5624.45%
SLNOSoleno Therapeutics Inc29.02-5687.57%
ASNDAscendis Pharma A/S30.09-5893.67%
LGNDLigand Pharmaceuticals Inc - Class B37.91-7400.83%
APLSApellis Pharmaceuticals Inc39.02-7614.44%
BMRNBiomarin Pharmaceutical Inc42.21-8228.87%
KRYSKrystal Biotech Inc45.34-8831.93%
ONCBeiGene Ltd69.54-13491.63%
PHARPharming Group N.V.75.03-14547.92%
TECHBio-Techne Corp101.96-19734.45%
VCELVericel Corp109.92-21267.91%
ALNYAlnylam Pharmaceuticals Inc117.96-22816.92%
GMABGenmab140.29-27116.25%
TLXTelix Pharmaceuticals Ltd162.15-31326.30%
CORTCorcept Therapeutics Inc212.86-41090.66%